PCSK9 (Alirocumab) Recombinant Monoclonal Antibody

• Gene Aliases:

  Convertase subtilisin/kexin type 9 preproprotein antibody; FH3 antibody; HCHOLA3 antibody; Hypercholesterolemia autosomal dominant 3 antibody; LDLCQ1 antibody; NARC 1 antibody; NARC-1 antibody; NARC1 antibody; Neural apoptosis regulated convertase 1 antibody; Neural apoptosis-regulated convertase 1 antibody; PC 9 antibody; PC9 antibody; PCSK 9 antibody; PCSK9 antibody; PCSK9_HUMAN antibody; Proprotein convertase 9 antibody; Proprotein convertase PC9 antibody; Proprotein convertase subtilisin/kexin type 9 antibody; PSEC0052 antibody; Subtilisin/kexin like protease PC9 antibody; Subtilisin/kexin-like protease PC9 antibody; Alirocumab

• UniProt:

  Q8NBP7

• Antigen Species:

  Human

• Reactivity:

  Human

• Target Antigen:

  Recombinant Human PCSK9 protein

• Target:

  PCSK9

• Clonality:

  Monoclonal

• Conjugation:

  Non-conjugated

• Field of Research:

  Cancer; Cardiovascular; Cell biology; Metabolism; Signal transduction; Stem cells

• Purification Method:

  Affinity-chromatography

• Form:

  Liquid

• Storage Conditions:

  Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

• Antibody Type:

  Recombinant Antibody

• Clone ID:

  9F1

• Tested Applications:

  ELISA; Recommended dilution: ELISA:1:5000-1:50000

• Isotype:

  IgG1